07/16/2025
We’re grateful to the Crohn's & Colitis Foundation for helping raise awareness about BOOM-IBD2, our new clinical trial studying neuromodulation for people living with ulcerative colitis.
The objective of the BOOM-IBD2 clinical trial is to evaluate the effectiveness of an investigational nerve stimulation (neuromodulation) device for ulcerative colitis (UC). This treatment involves implanting a small electronic device that delivers mild electrical pulses to a nerve near the tailbone....